9 results
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... for Management ... and Microscopic Polyangiitis ... #MPA #ACR2021 # ... Management #rheumatology
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
2021 ACR/VF Guidelines ... for Management ... Granulomatosis with Polyangiitis ... Granulomatosis #Polyangiitis ... #ACR2021 #Management
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... for Treatment & Management ... #Treatment #ACR2021 ... #Guidelines #algorithm
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Granulomatosis with Polyangiitis ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Fraction (HFrEF) - Guideline ... Beta-blocker • ACE ... Failure #CHF #HFrEF #Guideline ... #management #GDMT ... #cardiology
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Fraction (HFrEF) - Guideline ... Stepwise Approach: ACE ... Failure #CHF #HFrEF #Guideline ... #management #GDMT ... #cardiology #titration
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
HFrEF), we follow Guideline-Directed ... recommended by the ACC ... /AHA guidelines. ... #Pharmacology #Management ... Treatment #StageC #Cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
• Avoid ARB/ACE-I ... e.g., <50%), ESC guidelines ... pregnancy, teratogenic GDMT ... meds (e.g., ACE ... #cardiology #treatment